Jeffrey Vacirca
Impact in
- Cancer Research top 10%
- Protease and Inhibitor Mechanisms
- Oncology top 10%
- Peptidase Inhibition and Analysis
- Pancreatic and Hepatic Oncology Research
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Oncology 22
- Cancer Immunotherapy and Biomarkers 10
- Cancer Treatment and Pharmacology 3
- CAR-T cell therapy research 3
-
- Prostate Cancer Treatment and Research 6
- Co-authors
- Stanley Zucker (2 shared papers)Imad A. Tabbara (2 shared papers)Péter Ács (3 shared papers)Peter J. Rosen (2 shared papers)Peter P. Lee (1 shared paper)Tanios Bekaii‐Saab (1 shared paper)Philip J. Stephens (1 shared paper)Xiucai Hu (1 shared paper)
- Journals
- Journal of Clinical Oncology (13 papers)Blood (3 papers)Future Oncology (2 papers)Cancer Research (1 paper)Annals of Hematology (1 paper)
- Partner nations
- United StatesUnited KingdomPoland
In The Last Decade
Jeffrey Vacirca
29 papers receiving 737 citations
Peers
Comparison fields: 5 of 76
- Cancer Research 215
- Oncology 281
- Pathology and Forensic Medicine 111
- Immunology and Allergy 38
- Genetics 42
Countries citing papers authored by Jeffrey Vacirca
This map shows the geographic impact of Jeffrey Vacirca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey Vacirca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey Vacirca more than expected).
Fields of papers citing papers by Jeffrey Vacirca
This network shows the impact of papers produced by Jeffrey Vacirca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey Vacirca. The network helps show where Jeffrey Vacirca may publish in the future.
Co-authors
The 25 scholars most cited alongside Jeffrey Vacirca, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 436 | |
| 2 | 2015 | 75 | |
| 3 | 2013 | 74 | |
| 4 | 2018 | 42 | |
| 5 | 2016 | 21 | |
| 6 | 2016 | 17 | |
| 7 | 2010 | 11 | |
| 8 | 2018 | 10 | |
| 9 | 2018 | 9 | |
| 10 | 2018 | 7 | |
| 11 | 2017 | 6 | |
| 12 | 2013 | 5 | |
| 13 | 2014 | 5 | |
| 14 | 2010 | 5 | |
| 15 | 2005 | 5 | |
| 16 | 2019 | 4 | |
| 17 | 2009 | 3 | |
| 18 | 2017 | 3 | |
| 19 | 2010 | 3 | |
| 20 | The 340b drug discount program: oncology's optical illusion. | 2013 | 3 |
About Jeffrey Vacirca
Jeffrey Vacirca is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Genetics, Surgery and Cancer Research, having authored 32 papers that have together received 756 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (10 papers), Prostate Cancer Treatment and Research (6 papers), Nausea and vomiting management (5 papers), Lymphoma Diagnosis and Treatment (5 papers), Chronic Lymphocytic Leukemia Research (5 papers), Cancer Genomics and Diagnostics (4 papers), Cancer Treatment and Pharmacology (3 papers) and CAR-T cell therapy research (3 papers). The work is most often cited by research in Cancer Research (215 citations), Oncology (281 citations), Pathology and Forensic Medicine (111 citations), Immunology and Allergy (38 citations) and Genetics (42 citations). Jeffrey Vacirca has collaborated with scholars based in United States, United Kingdom and Poland. Frequent co-authors include Stanley Zucker, Imad A. Tabbara, Péter Ács, Peter J. Rosen, Peter P. Lee, Tanios Bekaii‐Saab, Philip J. Stephens, Xiucai Hu, Samuel J. Klempner and Kai Wang. Their work appears in journals such as Journal of Clinical Oncology, Blood, Future Oncology, Cancer Research and Annals of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.